Literature DB >> 21160160

The beneficial effects of tadalafil on renal ischemia-reperfusion injury in rats.

Mehmet Guzeloglu1, Fatih Yalcinkaya, Soner Atmaca, Alper Bagriyanik, Suleyman Oktar, Oguz Yuksel, Iyad Fansa, Eyup Hazan.   

Abstract

Acute renal failure due to ischemia-reperfusion (I/R) injury is a common complication in cardiovascular surgery. We determined the influence of tadalafil on renal injury in a renal I/R model in rats. For this purpose, 21 male Wistar albino rats were separated into 3 groups: sham, placebo and tadalafil. A right nephrectomy was performed, and the left renal pedicles were occluded for 60 min and reperfused for 60 min in the placebo and tadalafil groups. A single dose of tadalafil (10 mg/kg) through an orogastric tube was administered to the tadalafil group. Tubular atrophy with acute inflammation in renal histology, total oxidant status (TOS) and total antioxidant status (TAS) were determined in tissue homogenates. Compared to the tadalafil group, tubular atrophy and acute inflammation was significant in the placebo group. TAS levels were significantly higher in the tadalafil group compared to the placebo (p = 0.01) and sham groups (p = 0.04). While TOS levels were significantly higher in the placebo group (p = 0.03), tadalafil did not significantly alter the TOS levels. The beneficial effects of tadalafil can be attributed to its protective effects on renal tubular cells and inhibition of leukocyte infiltration in renal tissue. We think that tadalafil treatment has an important role in reducing renal injury resulting from renal I/R.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21160160     DOI: 10.1159/000321927

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  11 in total

1.  PDE5 inhibition against acute renal ischemia reperfusion injury in rats: does vardenafil offer protection?

Authors:  Iason Kyriazis; George C Kagadis; Panagiotis Kallidonis; Ioannis Georgiopoulos; Antonia Marazioti; Aikaterini Geronasiou; Despοina Liourdi; George Loudos; Vasilios Schinas; Dimitris Apostolopoulos; Helen Papadaki; Christodoulos Flordellis; George C Nikiforidis; Andreas Papapetropoulos; Evangelos Nu Liatsikos
Journal:  World J Urol       Date:  2012-11-10       Impact factor: 4.226

2.  The protective effect of tadalafil on IMA (ischemia modified albumin) levels in experimental renal ischemia-reperfusion injury.

Authors:  Akin Soner Amasyali; Abdullah Akkurt; Ercan Kazan; Mustafa Yilmaz; Bulent Erol; Yuksel Yildiz; Haluk Erol
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  The effects of tadalafil on renal ischemia reperfusion injury: an experimental study.

Authors:  Feyzul Gasanov; Berna Aytac; Hakan Vuruskan
Journal:  Bosn J Basic Med Sci       Date:  2011-08       Impact factor: 3.363

4.  Effects of phosphodiesterase-5 inhibitor on ischemic kidney injury during nephron sparing surgery: quantitative assessment by NGAL and KIM-1.

Authors:  Yousef Lahoud; Osamah Hussein; Amjad Shalabi; Omri Nativ; Hoda Awad; Mogher Khamaisi; Ibrahim Matar; Ofer Nativ; Zaid Abassi
Journal:  World J Urol       Date:  2015-05-16       Impact factor: 4.226

Review 5.  Phosphodiesterase type 5 inhibitors and kidney disease.

Authors:  Baris Afsar; Alberto Ortiz; Adrian Covic; Abduzhappar Gaipov; Tarik Esen; David Goldsmith; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2015-08-05       Impact factor: 2.370

Review 6.  Cyclic nucleotide signalling in kidney fibrosis.

Authors:  Elisabeth Schinner; Veronika Wetzl; Jens Schlossmann
Journal:  Int J Mol Sci       Date:  2015-01-22       Impact factor: 5.923

7.  The renoprotective effects of mannitol and udenafil in renal ischemia-reperfusion injury model.

Authors:  Yusuf Özlülerden; Cihan Toktaş; Hülya Aybek; Vural Küçükatay; Nilay Şen Türk; Ali Ersin Zumrutbas
Journal:  Investig Clin Urol       Date:  2017-06-27

8.  The protective effect of single dose tadalafil in contrast-induced nephropathy: an experimental study.

Authors:  Kerem Özbek; Köksal Ceyhan; Fatih Koç; Erkan Söğüt; Fatih Altunkaş; Metin Karayakalı; Ataç Çelik; Hasan Kadı; R Doğan Köseoğlu; Orhan Önalan
Journal:  Anatol J Cardiol       Date:  2014-04-16       Impact factor: 1.596

9.  Phosphodiesterase-5 inhibitors: emerging nephroprotective drugs.

Authors:  Zaid Abassi; Zaher Armaly
Journal:  Anatol J Cardiol       Date:  2015-04       Impact factor: 1.596

Review 10.  Current Concepts on the Reno-Protective Effects of Phosphodiesterase 5 Inhibitors in Acute Kidney Injury: Systematic Search and Review.

Authors:  Georgios Georgiadis; Ioannis-Erineos Zisis; Anca Oana Docea; Konstantinos Tsarouhas; Irene Fragkiadoulaki; Charalampos Mavridis; Markos Karavitakis; Stavros Stratakis; Kostas Stylianou; Christina Tsitsimpikou; Daniela Calina; Nikolaos Sofikitis; Aristidis Tsatsakis; Charalampos Mamoulakis
Journal:  J Clin Med       Date:  2020-04-29       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.